Frontiers in Pharmacology (Apr 2022)

Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study

  • Yusi Chen,
  • Jun Luo,
  • Jingyuan Chen,
  • Eugene Kotlyar,
  • Zilu Li,
  • Wenjie Chen,
  • Jiang Li

DOI
https://doi.org/10.3389/fphar.2022.891907
Journal volume & issue
Vol. 13

Abstract

Read online

No abstracts available.

Keywords